IP Verse

Insulin Formulations For Rapid Uptake

Patent No. EP3372238 (titled "Insulin Formulations For Rapid Uptake") was filed by ELI Lilly on Mar 3, 2010. The application was issued on Nov 18, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOHMANNAug 17, 2021BOHMANN
SCORPIOAug 16, 2021SAGITTARIUS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3372238

ELI LILLY
Application Number
EP18155633A
Filing Date
Mar 3, 2010
Status
Revoked
Jul 18, 2025
Publication Date
Nov 18, 2020
External Links
Slate, Register , Google Patents